143 related articles for article (PubMed ID: 9049184)
1. Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck.
Yeudall WA; Jakus J; Ensley JF; Robbins KC
Mol Carcinog; 1997 Feb; 18(2):89-96. PubMed ID: 9049184
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck.
Cardinali M; Kratochvil FJ; Ensley JF; Robbins KC; Yeudall WA
Mol Carcinog; 1997 Feb; 18(2):78-88. PubMed ID: 9049183
[TBL] [Abstract][Full Text] [Related]
3. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
5. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
Leng K; Schlien S; Bosch FX
J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
[TBL] [Abstract][Full Text] [Related]
6. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
7. Normalization of EGFR mRNA levels following restoration of wild-type p53 in a head and neck squamous cell carcinoma cell line.
Grandis JR; Zeng Q; Drenning SD; Tweardy DJ
Int J Oncol; 1998 Aug; 13(2):375-8. PubMed ID: 9664135
[TBL] [Abstract][Full Text] [Related]
8. The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes.
Yoo GH; Washington J; Oliver J; Piechocki M; Kim H; Foster-Nora J; Shibuya TY; Wilson DR; Ensley JF
Cancer; 2002 Jan; 94(1):159-66. PubMed ID: 11815972
[TBL] [Abstract][Full Text] [Related]
9. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region.
Hauser U; Balz V; Carey TE; Grénman R; Van Lierop A; Scheckenbach K; Bier H
Head Neck; 2002 Sep; 24(9):868-73. PubMed ID: 12211051
[TBL] [Abstract][Full Text] [Related]
10. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
Reiss M; Brash DE; Muñoz-Antonia T; Simon JA; Ziegler A; Vellucci VF; Zhou ZL
Oncol Res; 1992; 4(8-9):349-57. PubMed ID: 1486218
[TBL] [Abstract][Full Text] [Related]
11. Activation of PTHrP gene expression in squamous carcinoma cell lines by mutant isoforms of the tumor suppressor p53.
Foley J; King CS; Jiménez JA; Wysolmerski JJ; Philbrick WM
Oncol Res; 2000; 12(2):71-81. PubMed ID: 11132926
[TBL] [Abstract][Full Text] [Related]
12. [Significance of aberrant p53 protein in head-neck tumors and its effect on proliferation and differentiation].
Homann N; Andl T; Nees M; Schuhmann A; Herold-Mende C; Bosch FX
HNO; 1993 May; 41(5):254-60. PubMed ID: 8392993
[TBL] [Abstract][Full Text] [Related]
13. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
[TBL] [Abstract][Full Text] [Related]
14. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
[TBL] [Abstract][Full Text] [Related]
15. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines.
Burns JE; Baird MC; Clark LJ; Burns PA; Edington K; Chapman C; Mitchell R; Robertson G; Soutar D; Parkinson EK
Br J Cancer; 1993 Jun; 67(6):1274-84. PubMed ID: 8390283
[TBL] [Abstract][Full Text] [Related]
16. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
17. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
[TBL] [Abstract][Full Text] [Related]
18. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
19. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of p53 in head and neck cancer.
Watling DL; Gown AM; Coltrera MD
Head Neck; 1992; 14(6):437-44. PubMed ID: 1468914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
